Panel Discussion: Navigating the Regulatory Landscape in Allogeneic Product Development to Gain Clarity & Advance the Future of Universal Cell Therapies
Time: 3:30 pm
day: Conference Day Two
Details:
- Exploring the historical perspective that “your process is your product” and the implications of frequent process changes on regulatory submissions
- Examining key differences in regulatory expectations for allogeneic versus autologous therapies
- Discussing strategies for maintaining open communication with regulators to foster understanding and facilitate smoother approvals
